complimentary report
Navigate GenAI in Sales Tech: Balance Opportunities and Risks
We’re proud to share Templafy’s inclusion in a recent Gartner® report exploring how generative AI is transforming sales technology. Discover how organizations can harness GenAI’s productivity potential while managing security risks and ROI uncertainties in the evolving sales tech landscape.
“By 2028, 60% of B2B seller work will be executed through conversational user interfaces via GenAI sales technologies, up from less than 5% in 2023.”
A few of our key takeaways:
How generative AI is driving the next phase of sales AI through agentic systems that can plan, make decisions, and execute tasks autonomously - Strategic approaches for introducing agentic AI in high-value internal workflows like automating routine CRM tasks and generating price quotes
- Essential risk management practices when evaluating sales tech vendors, including data protection measures and output quality control
- Key market dynamics as vendors across the sales tech landscape rapidly integrate GenAI capabilities, creating both opportunities and challenges
Download your copy of this complimentary Gartner report to understand how generative AI is changing sales technology—including its benefits, risks, and what to consider when adopting new solutions.
Gartner, Navigate GenAI in Sales Tech: Balance Opportunities and Risks, By Dan Gottlieb, Guy Wood, Melissa Hilbert, Adnan Zijadic, 23 May 2025
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
